The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa
Open accessAbstract
Reliable genome editing via Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 may provide a means to correct inherited diseases in patients. As proof of principle, we show that CRISPR/Cas9 can be used in vivo to selectively ablate the rhodopsin gene carrying the dominant S334ter mutation (Rho(S334)) in rats that model severe autosomal dominant retinitis pigmentosa. A single subretinal injection of guide RNA/Cas9 plasmid in combination with electroporation generated allele-specific disruption of Rho(S334), which prevented retinal degeneration and improved visual function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., et al. (2015) · Nature · doi:10.1038/nature14592 · Cited by 1,624
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Electroporation and RNA interference in the rodent retina in vivo and in vitro
Matsuda, T., & Cepko, C. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235688100 · Cited by 1,029
Controlled expression of transgenes introduced by in vivo electroporation
Matsuda, T., & Cepko, C. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610155104 · Cited by 663
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Topkar, V. V., Zheng, Z., & Joung, J. K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3404 · Cited by 611
Lewin, A. S., Drenser, K. A., Hauswirth, W. W., Nishikawa, S., Yasumura, D., Flannery, J. G., & LaVail, M. M. (1998) · Nature Medicine · doi:10.1038/nm0898-967 · Cited by 407
Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy
Mendes, H. F., van der Spuy, J., Chapple, J. P., & Cheetham, M. E. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.007 · Cited by 377
Sung, C., Makino, C., Baylor, D., & Nathans, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-10-05818.1994 · Cited by 342
Mechanisms of Rhodopsin Inactivation in Vivo as Revealed by a COOH-Terminal Truncation Mutant
Chen, J., Makino, C. L., Peachey, N. S., Baylor, D. A., & Simon, M. I. (1995) · Science · doi:10.1126/science.7824934 · Cited by 311
Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors
Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01327-07 · Cited by 246
LaVail, M. M., Yasumura, D., Matthes, M. T., Drenser, K. A., Flannery, J. G., Lewin, A. S., & Hauswirth, W. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210319397 · Cited by 203
Non-Invasive Stem Cell Therapy in a Rat Model for Retinal Degeneration and Vascular Pathology
Wang, S., Lü, B., Girman, S., Duan, J., McFarland, T. J., Zhang, Q., Grompe, M., Adamus, G., Appukuttan, B., & Lund, R. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009200 · Cited by 144
Self-citationGreen, E. S., Menz, M. D., LaVail, M. M., & Flannery, J. G. (2000) · PubMed · Cited by 125
Beltran, W. A., Cideciyan, A. V., Iwabe, S., Świder, M., Kosyk, M. S., McDaid, K. S., Martynyuk, I., Ying, G., Shaffer, J., Deng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509914112 · Cited by 97
The Nature of Dominant Mutations of Rhodopsin and Implications for Gene Therapy
Wilson, J. H., & Wensel, T. G. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:2:149 · Cited by 90
Pennesi, M. E., Nishikawa, S., Matthes, M. T., Yasumura, D., & LaVail, M. M. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.09.004 · Cited by 88
Halting progressive neurodegeneration in advanced retinitis pigmentosa
Koch, S., Tsai, Y.-T., Duong, J., Wu, W.-H., Hsu, C., Wu, W., Bonet‐Ponce, L., Lin, C., & Tsang, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82462 · Cited by 87
Self-citationAdvances in gene therapy technologies to treat retinitis pigmentosa
Petrs‐Silva, H., & Linden, R. (2013) · Clinical ophthalmology · doi:10.2147/opth.s38041 · Cited by 81
Mussolino, C., Sanges, D., Marrocco, E., Bonetti, C., Vicino, U. D., Marigo, V., Auricchio, A., Meroni, G., & Surace, E. M. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000119 · Cited by 77
Expression of CRISPR/Cas single guide RNAs using small tRNA promoters
Mefferd, A. L., Kornepati, A. V. R., Bogerd, H. P., Kennedy, E. M., & Cullen, B. R. (2015) · RNA · doi:10.1261/rna.051631.115 · Cited by 74
The carboxyl-terminal domain is essential for rhodopsin transport in rod photoreceptors
Concepcion, F. A., Méndez, A., & Chen, J. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00195-x · Cited by 71
Human iPSC-Derived Neural Progenitors Preserve Vision in an AMD-Like Model
Tsai, Y.-C., Lü, B., Bakondi, B., Girman, S., Sahabian, A., Sareen, D., Svendsen, C. N., & Wang, S. (2015) · Stem Cells · doi:10.1002/stem.2032 · Cited by 53
Self-citationGene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller, B. P., Mao, H., & Lewin, A. S. (2012) · PubMed Central · Cited by 52
Retinal degeneration in two lines of transgenic S334ter rats
Martínez, G., Seiler, M. J., Aramant, R. B., Fernández‐Sánchez, L., Pinilla, I., & Cuenca, N. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.12.001 · Cited by 48
Optomotor and immunohistochemical changes in the juvenile S334ter rat
McGill, T. J., Prusky, G. T., Luna, G., LaVail, M. M., Fisher, S. K., & Lewis, G. P. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.09.006 · Cited by 20
Cited by
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
Applications of CRISPR technologies in research and beyond
Barrangou, R., & Doudna, J. A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3659 · Cited by 1,005
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Wang, D., Zhang, F., & Gao, G. (2020) · Cell · doi:10.1016/j.cell.2020.03.023 · Cited by 527
Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., da Silva Cunha, A., Woo, S. J., & Kwon, Y. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 413
Metadata
- Authors
- Bakondi, B., Lv, W., Lu, B., Jones, M. K., Tsai, Y., Kim, K. J., Levy, R., Akhtar, A. A., Breunig, J. J., Svendsen, C. N., & Wang, S.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 24
- Issue
- 3
- Pages
- 556-563
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2199356015
- Cited by
- 296
- References
- 27
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.